Another reported mechanism involves activation of an Alt3’ss in PPP2R5A, a protein phosphatase 2A subunit that promotes MYC stability and impairs apoptosis by increasing MYC S62 and BCL2 S70 phosphorylation in SF3B1-mutated tumors, including CLL (Liu et al, 2020). This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.